LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Return
10.14%
This Quarter Return
+5.57%
1 Year Return
+10.14%
3 Year Return
+35.76%
5 Year Return
+141%
10 Year Return
–
AUM
$1.13B
AUM Growth
+$64.3M
(+6%)
Cap. Flow
+$14.6M
Cap. Flow
% of AUM
1.29%
Top 10 Holdings %
Top 10 Hldgs %
44.8%
Holding
2,958
New
196
Increased
991
Reduced
1,088
Closed
128
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.24M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$3.66M |
| 3 |
Nuveen S&P 500 Buy-Write Income Fund
BXMX
|
+$2.96M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$2.82M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$1.9M |
Top Sells
| 1 |
Honeywell
HON
|
+$2.68M |
| 2 |
Aon
AON
|
+$2.32M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$1.8M |
| 4 |
NVIDIA
NVDA
|
+$1.79M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$1.64M |
Sector Composition
| 1 | Technology | 17.03% |
| 2 | Financials | 11.91% |
| 3 | Healthcare | 6.6% |
| 4 | Communication Services | 4.01% |
| 5 | Consumer Discretionary | 4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Performance Food Group
PFGC
$16.6B
| $28.3K | ﹤0.01% |
361
+26
| +8% | +$2.04K |
|
1102
First Financial Corporation Common Stock
THFF
$695M
| $28.2K | ﹤0.01% |
644
-70
| -10% | -$3.07K |
|
1103
Murphy USA
MUSA
$7.57B
| $28.1K | ﹤0.01% |
57
+2
| +4% | +$986 |
|
1104
Iovance Biotherapeutics
IOVA
$887M
| $28K | ﹤0.01% |
2,984
+292
| +11% | +$2.74K |
|
1105
Neurocrine Biosciences
NBIX
$14.2B
| $28K | ﹤0.01% |
243
+17
| +8% | +$1.96K |
|
1106
Avidity Biosciences
RNA
$5.28B
| $28K | ﹤0.01% |
609
+18
| +3% | +$827 |
|
1107
SPDR S&P 600 Small Cap Growth ETF
SLYG
$3.6B
| $27.9K | ﹤0.01% |
300
| – | – |
|
1108
Sylvamo
SLVM
$1.77B
| $27.9K | ﹤0.01% |
325
+8
| +3% | +$687 |
|
1109
Sabesp
SBS
$16B
| $27.9K | ﹤0.01% |
1,685
+928
| +123% | +$15.3K |
|
1110
UMB Financial
UMBF
$9.25B
| $27.9K | ﹤0.01% |
265
-5
| -2% | -$526 |
|
1111
Geron
GERN
$836M
| $27.8K | ﹤0.01% |
6,129
-329
| -5% | -$1.49K |
|
1112
Synchrony
SYF
$28.2B
| $27.7K | ﹤0.01% |
556
-472
| -46% | -$23.5K |
|
1113
HF Sinclair
DINO
$9.61B
| $27.7K | ﹤0.01% |
622
+134
| +27% | +$5.97K |
|
|
BPMC
1114
DELISTED
Blueprint Medicines
BPMC
| $27.7K | ﹤0.01% |
299
-14
| -4% | -$1.3K |
|
1115
Coca-Cola Consolidated
COKE
$10.8B
| $27.6K | ﹤0.01% |
210
+10
| +5% | +$1.32K |
|
1116
Howard Hughes
HHH
$4.82B
| $27.6K | ﹤0.01% |
357
+54
| +18% | +$4.18K |
|
1117
WesBanco
WSBC
$3.06B
| $27.6K | ﹤0.01% |
928
-196
| -17% | -$5.84K |
|
1118
Gray Television
GTN
$595M
| $27.6K | ﹤0.01% |
5,146
-494
| -9% | -$2.65K |
|
1119
Sasol
SSL
$4.53B
| $27.5K | ﹤0.01% |
4,069
-908
| -18% | -$6.14K |
|
1120
Insmed
INSM
$30.7B
| $27.4K | ﹤0.01% |
375
-143
| -28% | -$10.4K |
|
1121
BioMarin Pharmaceuticals
BMRN
$10.7B
| $27.3K | ﹤0.01% |
389
+111
| +40% | +$7.8K |
|
1122
XPeng
XPEV
$19.5B
| $27.3K | ﹤0.01% |
2,244
-176
| -7% | -$2.14K |
|
1123
Clearway Energy Class C
CWEN
$3.37B
| $27.3K | ﹤0.01% |
889
-35
| -4% | -$1.07K |
|
|
TXNM
1124
TXNM Energy, Inc.
TXNM
$6B
| $27.2K | ﹤0.01% |
622
-23
| -4% | -$1.01K |
|
1125
Oshkosh
OSK
$8.87B
| $27.2K | ﹤0.01% |
271
+27
| +11% | +$2.71K |
|